Search research articles
Contact Us
Filters
Showing results (21-30 of 88) with videos related to
Page
of 9
Sort By:
Pharmacogenomics
|
October 8, 2004
Pharmacogenetics of irinotecan toxicity
Sharon Marsh, Howard L McLeod
Personalized Medicine
|
May 12, 2018
eHealth: past and future perspectives
Tibor van Rooij, Sharon Marsh
Gastrointestinal Cancer Research : GCR
|
January 20, 2010
Challenges of incorporating pharmacogenomics into clinical practice
Sharon Marsh, Tibor van Rooij
Human Mutation
|
August 31, 2002
SNP databases and pharmacogenetics: great start, but a long way to go
Sharon Marsh, Pui Kwok, Howard L McLeod
Pharmacogenomics
|
March 7, 2006
Systems pharmacogenomics in yeast
Patrick Cahan, Sharon Marsh, Howard L McLeod
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC
|
July 8, 2015
AntiC: A practice tool for the safe use of oral chemotherapeutics by community and hospital pharmacists
Tibor van Rooij, Serena Rix, Sharon Marsh
Expert Review of Pharmacoeconomics & Outcomes Research
|
July 21, 2012
Personalized medicine policy challenges: measuring clinical utility at point of care
Tibor van Rooij, Donna M Wilson, Sharon Marsh
Clinical Pharmacology and Therapeutics
|
August 4, 2004
Caution with beta1-adrenergic receptor genotyping
David E Lanfear, Sharon Marsh, Howard L McLeod
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 17, 2005
Comment on "A frameshift mutation and alternate splicing in human brain generate a functional form of the pseudogene cytochrome P4502d7 that demethylates codeine to morphine", J Biol Chem 279: 27383-27389
Janelle M Hoskins, Sharon Marsh, Howard L McLeod
Clinical Colorectal Cancer
|
June 24, 2004
Application of pharmacogenomics in the individualization of chemotherapy for gastrointestinal malignancies
Howard L McLeod, Cristi R King, Sharon Marsh
Page
of 9
Search research articles
Search
Showing results (21-30 of 88) with videos related to
Sort By:
Page
of 9
Pharmacogenomics
|
October 8, 2004
Pharmacogenetics of irinotecan toxicity
Sharon Marsh, Howard L McLeod
Personalized Medicine
|
May 12, 2018
eHealth: past and future perspectives
Tibor van Rooij, Sharon Marsh
Gastrointestinal Cancer Research : GCR
|
January 20, 2010
Challenges of incorporating pharmacogenomics into clinical practice
Sharon Marsh, Tibor van Rooij
Human Mutation
|
August 31, 2002
SNP databases and pharmacogenetics: great start, but a long way to go
Sharon Marsh, Pui Kwok, Howard L McLeod
Pharmacogenomics
|
March 7, 2006
Systems pharmacogenomics in yeast
Patrick Cahan, Sharon Marsh, Howard L McLeod
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC
|
July 8, 2015
AntiC: A practice tool for the safe use of oral chemotherapeutics by community and hospital pharmacists
Tibor van Rooij, Serena Rix, Sharon Marsh
Expert Review of Pharmacoeconomics & Outcomes Research
|
July 21, 2012
Personalized medicine policy challenges: measuring clinical utility at point of care
Tibor van Rooij, Donna M Wilson, Sharon Marsh
Clinical Pharmacology and Therapeutics
|
August 4, 2004
Caution with beta1-adrenergic receptor genotyping
David E Lanfear, Sharon Marsh, Howard L McLeod
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 17, 2005
Comment on "A frameshift mutation and alternate splicing in human brain generate a functional form of the pseudogene cytochrome P4502d7 that demethylates codeine to morphine", J Biol Chem 279: 27383-27389
Janelle M Hoskins, Sharon Marsh, Howard L McLeod
Clinical Colorectal Cancer
|
June 24, 2004
Application of pharmacogenomics in the individualization of chemotherapy for gastrointestinal malignancies
Howard L McLeod, Cristi R King, Sharon Marsh
Page
of 9